Stocks of giant surge after legal advance in the USA

The sharp drop in Bayer's shares marked the beginning of the week in international markets and put the judicial dispute involving the herbicide Roundup back at the center of the debate. The move reflected the immediate reaction of investors after a new step by the United States government altered the landscape of litigation linked to glyphosate, an issue that has been pressuring the company for years. The jump occurred after the administration of then-President Donald Trump recommended that the Supreme Court review Bayer's appeal to limit lawsuits that link the product to cancer risk. The dispute has been following the company since the purchase of Monsanto for 63 billion dollars in 2018, an operation that incorporated a large-scale liability. With federal support, Bayer's shares advanced more than 12% in European trading. In a document sent to the Court, Attorney General D. John Sauer argued that federal pesticide legislation should prevail over state labeling requirements. He ...